» Articles » PMID: 36135175

MiR-942-3p As a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2022 Sep 22
PMID 36135175
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is a common tumor with high morbidity and mortality. MicroRNA (miRNA) can regulate gene expression at the translation level and various tumorigenesis processes, playing an important role in tumor occurrence and prognosis. This study aims to screen miRNA associated with gastric cancer prognosis as biomarkers and explore the regulatory genes and related signaling pathways. In this work, R language was used for the standardization and differential analysis of miRNA and mRNA expression profiles. Samples were randomly divided into a testing group and a training group. Subsequently, we built the five miRNAs (has-miR-9-3p, has-miR-135b-3p, has-miR-143-5p, has-miR-942-3p, has-miR-196-3p) prognostic modules, verified and evaluated their prediction ability by the Cox regression analysis. They can be used as an independent factor in the prognosis of gastric cancer. By predicting and analyzing potential biological functions of the miRNA target genes, this study found that the AR gene was not only a hub gene in the PPI network, but also associated with excessive survival of patients. In conclusion, this study demonstrated that hsa-miR-942-3p could be a potential prognostic marker of gastric cancer associated with the AR and MAPK/ERK signaling pathways. The results of this study provide insights into the occurrence and development of gastric cancer.

Citing Articles

Functions of Hemp-Induced Exosomes against Periodontal Deterioration Caused by Fine Dust.

Kim E, Park Y, Yun M, Kim B Int J Mol Sci. 2024; 25(19).

PMID: 39408660 PMC: 11477052. DOI: 10.3390/ijms251910331.


The Role of Circular RNA in the Pathogenesis of Chemotherapy-Induced Cardiotoxicity in Cancer Patients: Focus on the Pathogenesis and Future Perspective.

Joghataie P, Bakhshi Ardakani M, Sabernia N, Salary A, Khorram S, Sohbatzadeh T Cardiovasc Toxicol. 2024; 24(11):1151-1167.

PMID: 39158829 DOI: 10.1007/s12012-024-09914-w.


A hub gene signature as a therapeutic target and biomarker for sepsis and geriatric sepsis-induced ARDS concomitant with COVID-19 infection.

Qian G, Fang H, Chen A, Sun Z, Huang M, Luo M Front Immunol. 2023; 14:1257834.

PMID: 37822934 PMC: 10562607. DOI: 10.3389/fimmu.2023.1257834.


Molecules at Play in Cancer.

Iacobas D Curr Issues Mol Biol. 2023; 45(3):2182-2185.

PMID: 36975510 PMC: 10047071. DOI: 10.3390/cimb45030140.

References
1.
Zhang C, Zhang C, Ma M, Dai D . Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. World J Gastroenterol. 2018; 24(11):1206-1215. PMC: 5859223. DOI: 10.3748/wjg.v24.i11.1206. View

2.
Yang J, Zhang H, Qin C . MicroRNA-217 functions as a prognosis predictor and inhibits pancreatic cancer cell proliferation and invasion via targeting E2F3. Eur Rev Med Pharmacol Sci. 2017; 21(18):4050-4057. View

3.
Gires O . Lessons from common markers of tumor-initiating cells in solid cancers. Cell Mol Life Sci. 2011; 68(24):4009-22. PMC: 11114982. DOI: 10.1007/s00018-011-0772-9. View

4.
McCubrey J, Steelman L, Chappell W, Abrams S, Wong E, Chang F . Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2006; 1773(8):1263-84. PMC: 2696318. DOI: 10.1016/j.bbamcr.2006.10.001. View

5.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View